HIV-1 drug resistance testing is essential for heavily-treated patients switching from first- to second-line regimens in resource-limited settings: evidence from routine clinical practice in Cameroon

BACKGROUND: With the phase-out of stavudine (d4T), change to first-line regimens with zidovudine (AZT) or tenofovir (TDF) in resource-limited settings (RLS) might increase risks of cross-resistance to nucleos(t) ide reverse transcriptase inhibitors (NRTI). This would restrict the scope of switching...

Descripción completa

Detalles Bibliográficos
Autores principales: Takou, Desire, Fokam, Joseph, Teto, Georges, Santoro, Maria-Mercedes, Ceccherini-Silberstein, Francesca, Nanfack, Aubin Joseph, Sosso, Samuel Martin, Dambaya, Béatrice, Salpini, Romina, Billong, Serge Clotaire, Gori, Caterina, Fokunang, Charles Ntungwen, Cappelli, Giulia, Colizzi, Vittorio, Perno, Carlo-Federico, Ndjolo, Alexis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419466/
https://www.ncbi.nlm.nih.gov/pubmed/30871487
http://dx.doi.org/10.1186/s12879-019-3871-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419466/
https://www.ncbi.nlm.nih.gov/pubmed/30871487
http://dx.doi.org/10.1186/s12879-019-3871-0

Ejemplares similares